Detoxication enzyme inducers modify cytokine production in rat mixed glial cells.
about
The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stressOptimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of actionUtilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other DiseasesCellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disordersDevelopment of oral immunomodulatory agents in the management of multiple sclerosisEffects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouseCurrent and emerging therapies in multiple sclerosis: a systematic reviewEfficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease.Fumaric Acid and its esters: an emerging treatment for multiple sclerosis.Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia.Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosisEfficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS).Emerging therapies for treatment of multiple sclerosisDimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes.Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.Positively Charged Oligo[Poly(Ethylene Glycol) Fumarate] Scaffold Implantation Results in a Permissive Lesion Environment after Spinal Cord Injury in RatDimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROS increase/MAPKs activation pathway.Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line.Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy.Antioxidant therapy in multiple sclerosis.Anti-inflammatory potential of allyl-isothiocyanate--role of Nrf2, NF-(κ) B and microRNA-155.Fumarates for the treatment of multiple sclerosis: potential mechanisms of action and clinical studies.Drugs in development for relapsing multiple sclerosis.Dimethyl fumarate : a Janus-faced substance?The benefits and detriments of macrophages/microglia in models of multiple sclerosisDimethyl fumarate (BG-12) for the treatment of multiple sclerosis.Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects.Dimethyl fumarate for treating relapsing multiple sclerosis.Recent advances in the treatment of multiple sclerosis.Suppression of LPS-induced transcription and cytokine secretion by the dietary isothiocyanate sulforaphane.Multiple Sclerosis and Subsequent Human Immunodeficiency Virus Infection: A Case with the Rare Comorbidity, Focus on Novel Treatment Issues and Review of the Literature.Sulforaphane reduces lipopolysaccharide-induced proinflammatory markers in hippocampus and liver but does not improve sickness behavior.LPS-induced expression of CD14 in the TRIF pathway is epigenetically regulated by sulforaphane in porcine pulmonary alveolar macrophages.Dimethyl Fumarate Modulates Oxidative Stress and Inflammation in Organs After Sepsis in Rats.Assessment of an imiquimod-induced psoriatic mouse model in relation to oxidative stress.Sulforaphane inhibits IL-1β-induced proliferation of rheumatoid arthritis synovial fibroblasts and the production of MMPs, COX-2, and PGE2.Chronic uranium exposure dose-dependently induces glutathione in rats without any nephrotoxicity.
P2860
Q24648021-31F93706-C5DE-4A5C-8BB2-6712674CF41CQ26822611-07ABD842-86AD-4F6B-BB26-F0932FE61F3FQ28078742-6236B237-2AEA-4B04-A97C-17A402C5DEDCQ28384232-7AF03A76-9A4E-40D6-BC48-FD981F322904Q28388704-06DAB4D3-F294-40D0-A963-248FC52730FBQ28750219-C82BF67E-6144-4B59-886B-C7A28BC6410BQ29010983-060A7323-8783-42B5-A6CB-7E379BC8435CQ33812932-54D5A84A-7FFF-46D7-884D-F1693992E8FDQ34611373-2F11D42B-D9E5-44BB-A5EF-1671FDD3D2C7Q34627230-89F1B448-926A-4C7E-ACE7-2E7918193A25Q34631940-25454985-A53D-41FC-82F1-AFC759F1FF38Q34773115-467CAED5-0A16-45E1-974B-6F4046F01796Q34998538-4827BD48-6B92-4CBC-BD91-D00A8C2797C6Q35078252-461A4B02-C1CB-4921-B6AC-D46191F0A195Q35181833-D3C2005C-17F3-4B98-8EC9-4AF839750A90Q35557390-DD010C73-2587-42CD-8188-C6894911D041Q35594174-51B020FB-DC58-42D5-B0AD-43B91D7CD57EQ35856171-3CC258E1-A401-4999-B0BB-3933CF304F5AQ35865332-3EFB7543-88F7-44AE-9EC7-2B4DA53FC219Q35911773-6532351C-AEFF-416C-8508-340AD734F714Q36321714-18A1FDBC-2A36-4B25-8D70-107BE81CC6B7Q37122279-A8B05407-C31F-4785-A406-F8BF849A3586Q37258404-39A78A32-E3A0-4E8F-9611-789D54DC6832Q37294637-92FA79C7-043C-4F7C-B5C8-8EFA1383E2DBQ37318146-BFA5C1EE-9A83-45F8-90C8-989F4EEF0A30Q38101004-0D3C938E-1A96-4986-8D51-1E6B63665CCBQ38108633-DA719B33-9F8D-4A9B-821D-06CE5078BB6BQ38120527-018619AA-0A59-4E44-AEF3-CFCAD90B5089Q38127463-58E28D98-2E4E-4786-BD9A-FCDC6FF2FC0FQ38141840-E9CA66A5-5068-49C5-A4B7-37138700BF78Q38266397-169F3FF0-1E6A-4883-AFA9-59F394307600Q38836048-308A5994-8798-4B1C-B358-D188D15AAA87Q38950403-C8655610-67C0-44E9-BA94-B6058565CBE8Q40052430-2DA3282D-AD07-49F9-AC23-72625EBF02F2Q40240331-C31A9D60-F89A-483D-8E9B-C9FAA5D8B9BBQ40521509-60D12E19-EF5D-4095-A3FE-69FB53FCBE72Q47417790-C8C7514C-B367-4168-B2A1-997963FD7CE7Q51320292-6D36A30C-34A4-433B-BD07-DEC6DF322419Q53060495-E9419691-75EB-477B-B394-5DAF142EF9E9Q54197632-4F299439-8EE7-40A6-BA9F-9272C61601C0
P2860
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells.
@en
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells.
@nl
type
label
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells.
@en
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells.
@nl
prefLabel
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells.
@en
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells.
@nl
P2093
P1476
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells.
@en
P2093
Anne Wierinckx
Anne-Marie Van Dam
Dominique Mercier
John Brevé
P304
P356
10.1016/J.JNEUROIM.2005.05.013
P577
2005-09-01T00:00:00Z